Found: 156
Select item for more details and to access through your institution.
P‐tau235: a novel biomarker for staging preclinical Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 12, p. 1, doi. 10.15252/emmm.202115098
- By:
- Publication type:
- Article
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 12, p. 1, doi. 10.15252/emmm.202012921
- By:
- Publication type:
- Article
Blood–brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 865, doi. 10.1093/brain/awac459
- By:
- Publication type:
- Article
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. 1152, doi. 10.1093/brain/awac407
- By:
- Publication type:
- Article
Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5324, doi. 10.1002/alz.13907
- By:
- Publication type:
- Article
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 4199, doi. 10.1002/alz.13829
- By:
- Publication type:
- Article
Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2894, doi. 10.1002/alz.13711
- By:
- Publication type:
- Article
Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p‐tau217.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 3114, doi. 10.1002/alz.13708
- By:
- Publication type:
- Article
Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1166, doi. 10.1002/alz.13528
- By:
- Publication type:
- Article
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1284, doi. 10.1002/alz.13518
- By:
- Publication type:
- Article
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 745, doi. 10.1002/alz.13516
- By:
- Publication type:
- Article
Independent associations of plasma GFAP with amyloid‐β and tau in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083173
- By:
- Publication type:
- Article
Optimizing plasma biomarkers combinations for the detection of amyloid pathology in cognitively unimpaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082742
- By:
- Publication type:
- Article
Increased Genetic Risk for ADHD Potentiates Cognitive Impairment and Brain Hypometabolism in Alzheimer's Disease Patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080519
- By:
- Publication type:
- Article
Interactions of synaptic and inflammatory biomarkers in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080593
- By:
- Publication type:
- Article
Fast accumulators of tau have higher levels of plasma pTau and stronger associations with amyloid in later Braak regions at baseline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079999
- By:
- Publication type:
- Article
Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079000
- By:
- Publication type:
- Article
Amyloid‐dependent tau phosphorylation drives faster accumulation of tau aggregates in female.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078657
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077921
- By:
- Publication type:
- Article
The impact of young controls in the detection of tau load in cognitively impaired and asymptomatic elderly.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076833
- By:
- Publication type:
- Article
Investigating Potential Racial Differences in Dementia‐Related Plasma Biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080261
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080098
- By:
- Publication type:
- Article
Microtubule‐binding region tau fragment tau368 as a biomarker of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079611
- By:
- Publication type:
- Article
The role of biofluid markers in predicting near‐term cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079372
- By:
- Publication type:
- Article
Examination of plasma YKL‐40 as a clinical biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078885
- By:
- Publication type:
- Article
Plasma Alzheimer biomarkers in the 1946 British birth cohort: predicting conversion to amyloid PET positivity over a two‐year follow‐up period.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078425
- By:
- Publication type:
- Article
Cognitively Unimpaired Multiparous Women Have Higher CSF p‐tau181 Levels Which Have More Deleterious Effects on Neurodegeneration and Executive Function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078157
- By:
- Publication type:
- Article
Plasma p‐tau forms as potential diagnostic biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077124
- By:
- Publication type:
- Article
The clinical usefulness of plasma biomarkers of neuronal dysfunction in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076874
- By:
- Publication type:
- Article
Development and implementation of plasma P‐tau immunoassays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080658
- By:
- Publication type:
- Article
Plasma biomarkers as stand‐alone tests in the diagnosis of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080181
- By:
- Publication type:
- Article
Plasma biomarkers rates of change across the preclinical stage of Alzheimer's disease: a longitudinal study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079638
- By:
- Publication type:
- Article
Plasma biomarkers in relation to spatial distribution of Alzheimer's disease neuropathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078416
- By:
- Publication type:
- Article
Plasma p‐tau212 is an early biomarker to identify Alzheimer's Disease pathology in Down Syndrome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076229
- By:
- Publication type:
- Article
Sex Differences on Tau, Astrocytic and Neurodegeneration Plasma Biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.071807
- By:
- Publication type:
- Article
Interactions of synaptic and inflammatory biomarkers in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082018
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081969
- By:
- Publication type:
- Article
The role of biofluid markers in predicting near‐term cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081897
- By:
- Publication type:
- Article
Increased regional brain inflammation predicts longitudinal brain atrophy in individuals in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081863
- By:
- Publication type:
- Article
Plasma biomarkers in relation to spatial distribution of Alzheimer's disease neuropathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081810
- By:
- Publication type:
- Article
Exploring biomarker profiles of the cognitively unimpaired individuals in early tau PET Braak stage.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081775
- By:
- Publication type:
- Article
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5620, doi. 10.1002/alz.13318
- By:
- Publication type:
- Article
Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 4967, doi. 10.1002/alz.13026
- By:
- Publication type:
- Article
Preanalytical stability of plasma/serum brain‐derived tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4764, doi. 10.1002/alz.13156
- By:
- Publication type:
- Article
Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4335, doi. 10.1002/alz.13157
- By:
- Publication type:
- Article
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4507, doi. 10.1002/alz.12986
- By:
- Publication type:
- Article